The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1β, TNF-α, PTH, PTHrP, and 1,25(OH)2D3.
Open accessAbstract
Osteoprotegerin (OPG) is a secreted protein that inhibits osteoclast formation and activity and appears to be a critical regulator of bone mass and metabolism. In the current study, mice were challenged with various cytokines and hormones (interleukin-1β, tumor necrosis factor-α, parathyroid hormone, parathyroid hormone-related protein, and 1α,25-dihydroxyvitamin D3) that are known to increase bone resorption and cause hypercalcemia and treated concurrently with either a recombinant chimeric Fc fusion form of human OPG, with enhanced biological activity (cOPG) (2.5 mg/kg/day) or vehicle. Mice receiving these bone-resorbing factors became hypercalcemic by day 3 after commencing treatment and had increased bone resorption as evidenced by elevated osteoclast numbers on day 5. Concurrent cOPG treatment prevented hypercalcemia (p < 0.05) and maintained osteoclast numbers in the normal range (p < 0.001). The demonstration that cOPG can inhibit bone resorption suggests that this molecule may be useful in the treatment of diseases including hyperparathyroidism, humoral hypercalcemia of malignancy, osteoporosis, and inflammatory bone disease, which are characterized, in part, by increases in osteoclastic bone resorption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In support of the latter notion, OPG treatment of mice was able to fully prevent the proresorptive effects of IL-1 and TNF-␣ (21).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [21]
In the citing paper
“OPG prevents the ability of proresorptive agents (IL-1, TNF-␣, PTH, PTHrP, vitamin D) to increase bone resorption in mice (21), which is consistent with the interpretation that those agents increase bone resorption by increasing the RANKL:OPG ratio.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multiple Comparison Procedure for Comparing Several Treatments with a Control
Dunnett, C. W. (1955) · Journal of the American Statistical Association · doi:10.1080/01621459.1955.10501294 · Cited by 6,097
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Self-citationOsteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Self-citationYasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Self-citationA homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201
Wong, B. R., Rho, J., Arron, J. R., Robinson, E. A., Orlinick, J. R., Chao, M. V., Kalachikov, S. M., Cayani, E., Bartlett, F. S., Frankel, W. N., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25190 · Cited by 1,042
An interleukin 1 like factor stimulates bone resorption in vitro
Gowen, M., Wood, D. D., Ihrie, E. J., McGuire, M. K. B., & Russell, R. G. G. (1983) · Nature · doi:10.1038/306378a0 · Cited by 1,012
Arend, W. P., & Dayer, J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380202 · Cited by 891
Cited by
Sorted by citations
Items 101–187 of 187
Deligiorgi, M. V., Panayiotidis, M. I., Grınıatsos, J., & Trafalis, D. T. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-09997-8 · Cited by 32
Halladay, D., Miles, R. R., Thirunavukkarasu, K., Chandrasekhar, S., Martin, T. J., & Onyia, J. E. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1273 · Cited by 32
Lerner, U. H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1298851 · Cited by 39
Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice
Arlt, H., Mullarkey, T. L., Hu, D. Z., Baron, R., Ominsky, M. S., Mitlak, B., Lanske, B., & Besschetnova, T. Y. (2020) · Bone Reports · doi:10.1016/j.bonr.2020.100291 · Cited by 31
Emerging therapies for osteoporosis
Gowen, M., Emery, J. G., & Kumar, S. (2000) · Emerging Drugs · doi:10.1517/14728214.5.1.1 · Cited by 31
Quinn, J. E., Brown, L. G., Zhang, J., Keller, E. T., Vessella, R. L., & Corey, E. (2005) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500815 · Cited by 29
Historical Overview of Vitamin D
DeLuca, H. F. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10001-0 · Cited by 29
OPG, RANKL, and RANK in Cancer Metastasis: Expression and Regulation
Brown, J. M., Zhang, J., & Keller, E. T. (2004) · Cancer treatment and research · doi:10.1007/978-1-4419-9129-4_7 · Cited by 28
Lorch, G., Gilmore, J. L., Koltz, P. F., Gonterman, R. M., Laughner, R., Lewis, D. A., Konger, R. L., Nadella, K. S., Toribio, R. E., Rosol, T. J., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603828 · Cited by 28
Treatment of malignant hypercalcaemia
Esbrit, P., & Hurtado, J. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.5.521 · Cited by 28
Excessive dietary intake of vitamin A reduces skull bone thickness in mice
Lind, T., Öhman‐Mägi, C., Calounova, G., Rasmusson, A. J., Andersson, G. N., Pejler, G., & Melhus, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176217 · Cited by 27
Therapeutic effect of aqueous extract from Ecliptae herba on bone metabolism of ovariectomized rats
Zhang, Z., Bai, D., Liu, M.-J., Li, Y., Pan, J., Liu, H., Wang, W., Xiang, L., Xiao, G. G., & Ju, D. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318265e7dd · Cited by 26
Modulation of osteoclast function in bone by the immune system
Quinn, J. M. W., & Saleh, H. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.002 · Cited by 28
Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases
Cho, C. H., & NUTTALL, M. E. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.6.679 · Cited by 25
Miossec, P. (2008) · Biologics · doi:10.2147/btt.s2338 · Cited by 27
Emerging and potential therapies for osteoporosis
Grey, A. B., & Reid, I. R. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.3.265 · Cited by 22
Tao, H., Okamoto, M., Nishikawa, M., Yoshikawa, H., & Myoui, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023199 · Cited by 22
Osteoprotegerin ameliorates sciatic nerve crush induced bone loss.
Bateman, T. A., Dunstan, C. R., Lacey, D. L., Ferguson, V. L., Ayers, R. A., & Simske, S. J. (2001) · Journal of Orthopaedic Research · doi:10.1016/s0736-0266(00)00057-7 · Cited by 22
Self-citationPTH and PTHrP Actions on Kidney and Bone
Bisello, A., & Friedman, P. A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00050-1 · Cited by 23
Feige, U. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.90003.iii81 · Cited by 22
Osteoprotegerin Abrogates Chronic Alcohol Ingestion-Induced Bone Loss in Mice
Zhang, J., Dai, J., Lin, D., Habib, P., Smith, P., Murtha, J., Fu, Z., Yao, Z., Qi, Y., & Keller, E. T. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.7.1256 · Cited by 20
Cellular Actions of Parathyroid Hormone on Osteoblast and Osteoclast Differentiation
Aubin, J. E., & Heersche, J. N. M. (2001) · Elsevier eBooks · doi:10.1016/b978-012098651-4/50014-6 · Cited by 20
Bone remodeling humoral networks and smart biomaterial technology for osteoporosis
Fini, M. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s79 · Cited by 19
Transmembrane protein 173 inhibits RANKL‐induced osteoclast differentiation
Choe, C.-H., Park, I. S., Park, J., Yu, K.-Y., Jang, H.-S., Kim, J., & Jang, Y. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.02.018 · Cited by 17
Doumouchtsis, K., Perrea, D. N., Doumouchtsis, S. K., Tziamalis, M. P., Poulakou, M. V., Vlachos, I. S., & Kostakis, A. (2009) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2009.00653.x · Cited by 17
Ma, W., Jin, W., He, X., Sun, Y., Yin, H., Wang, Z., & Shi, S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.780272 · Cited by 17
Ross, F. P., & Teitelbaum, S. L. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50004-0 · Cited by 16
Marker of Bone Resorption in Acute Response to Exogenous or Endogenous Parathyroid Hormone.
Zikán, V., & Stepan, J. J. (2008) · Europe PMC (PubMed Central) · Cited by 16
Enomoto, T., Furuya, Y., Tomimori, Y., Mori, K., Miyazaki, J., & Yasuda, H. (2010) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-010-0235-7 · Cited by 15
Systemic and local effects of radiotherapy: an experimental study on implants placed in rats
Vegian, M. R. D. C., Costa, B. C. A., Santana-Melo, G. D. F., Godoi, F. H. C., Kaminagakura, E., Tango, R. N., do Prado, R. F., de Oliveira, L. D., Federico, C. A., Avelino, S. D. O. M., et al. (2019) · Clinical Oral Investigations · doi:10.1007/s00784-019-02946-5 · Cited by 17
Iguchi, H., Aramaki, Y., Maruta, S., & Takiguchi, S. (2005) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-005-0640-5 · Cited by 15
Jensen, T. S., Hansen, M., Madsen, J. C., Kollerup, G., Stoltenberg, M., Florescu, A., & Schwarz, P. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510152567130 · Cited by 14
Marker of Bone Resorption in Acute Response to Exogenous or Endogenous Parathyroid Hormone
Zikán, V., & Stepan, J. J. (2008) · Biomarker Insights · doi:10.1177/117727190800300005 · Cited by 14
DeLuca, H. F. (2005) · Elsevier eBooks · doi:10.1016/b978-012252687-9/50004-8 · Cited by 14
Morony, S., Warmington, K. S., Adamu, S., Asuncion, F., Geng, Z., Grisanti, M. S., Tan, H. L. E., Capparelli, C., Starnes, C. O., Dunstan, C. R., et al. (2005) · Cited by 13
Self-citationKam, W. W.-Y., Meikle, S. R., Dunstan, C. R., & Banati, R. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030623 · Cited by 12
Self-citationTherapeutic Effects ofCortex acanthopanacisAqueous Extract on Bone Metabolism of Ovariectomized Rats
Zhang, Z., Dong, J., Liu, M., Li, Y., Pan, J., Liu, H., Wang, W., Bai, D., Xiang, L., Xiao, G. G., et al. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/492627 · Cited by 13
Fattore, A. D., Cappariello, A., Capulli, M., Rucci, N., Muraca, M., Benedetti, F. D., & Teti, A. M. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2479-2 · Cited by 11
On the Evolution and Contemporary Roles of Bone Remodeling
Kostenuik, P. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00037-6 · Cited by 11
Novel approaches to the management of bone metastases
Hortobágyi, G. N. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.018 · Cited by 11
Renal and Skeletal Actions of Parathyroid Hormone (PTH) and PTH-Related Protein
Bringhurst, F. R., & Strewler, G. J. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50130-x · Cited by 11
Perspectives on osteoporosis in pediatric inflammatory bowel disease
Harpavat, M., & Keljo, D. J. (2003) · Current Gastroenterology Reports · doi:10.1007/s11894-003-0024-8 · Cited by 10
Khapli, S. M., Tomar, G. B., Barhanpurkar, A. P., Gupta, N., Yogesha, S. D., Pote, S. T., & Wani, M. R. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.143 · Cited by 9
Kitchens, J. A., Schwartz, S. A., Schindler, W. G., & Hargreaves, K. (2007) · Journal of Endodontics · doi:10.1016/j.joen.2007.06.017 · Cited by 8
Mundy, G. R., Oyajobi, B. O., Traianedes, K., Dallas, S. L., & Chen, D. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50014-3 · Cited by 8
Miyaji, Y., Kurihara, A., Kamiyama, E., Shiiki, T., Kawai, K., & Okazaki, O. (2009) · Xenobiotica · doi:10.1080/00498250802590745 · Cited by 7
Local delivery of osteoprotegerin may be a way of reinforcing orthodontic anchorage
Li, Y., & Tang, L. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.09.022 · Cited by 5
Miyaji, Y., Kasuya, Y., Furuta, Y., Kurihara, A., Takahashi, M., Ogawara, K., Izumi, T., Okazaki, O., & Higaki, K. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0807-4 · Cited by 5
Historical Overview of Vitamin D
DeLuca, H. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809965-0.00001-x · Cited by 5
High-fat diet, intestinal microecology and bone loss
Wang, N., Xue, T., & Li, Y. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-01013-z · Cited by 4
Jin, M., Chen, Y., Zhao, Y., Che, L., Ma, Y., Li, J., Wang, Y., Tao, H., Ma, J., Pan, B., et al. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8188-6 · Cited by 4
Xiao, L.-Q., Wang, H.-T., Li, Y., Zeng, Q., Zhou, E., Ni, X., & Huan, Z.-P. (2015) · PubMed · Cited by 4
Gruber, H. E., & Rude, R. K. (2003) · Biotechnic & Histochemistry · doi:10.1080/10320290310001630476 · Cited by 4
Guidon, C. (2005) · EMC-Anesthésie réanimation/Encyclopédie médico-chirurgicale. Anesthésie, réanimation · doi:10.1016/j.emcar.2005.01.001 · Cited by 4
RANKL (Receptor activator of NFκB ligand)
Blake, S., & JAMES, I. (2003) · Elsevier eBooks · doi:10.1016/b978-012689663-3/50041-7 · Cited by 4
Parathyroid hormone and parathyroid hormone–related protein actions on bone and kidney
Bisello, A., & Friedman, P. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00027-0 · Cited by 3
Der RANK-Ligand-Antikörper Denosumab als Beispiel der biotechnologischen Medikamentenentwicklung
Trubrich, A., Kocijan, R., Muschitz, C., & Resch, H. (2011) · Osteologie/Osteology · doi:10.1055/s-0037-1619994 · Cited by 3
Arai, S., Amizuka, N., Azuma, Y., Takeshita, S., & Kudō, A. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.4.686 · Cited by 3
The influence of parasitic infection (Eimeria spp.) on bone and cartilage tissue in an animal model
Tomczyk‐Warunek, A., Muszyński, S., Tomaszewska, E., Dobrowolski, P., Arczewska-Włosek, A., Świątkiewicz, S., & Józefiak, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-22579-x · Cited by 3
On the evolution and contemporary roles of bone remodeling
Kostenuik, P. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00031-9 · Cited by 3
Rôle de l’ostéoprotégérine dans l’inflammation et la polyarthrite rhumatoïde
Saidenberg-Kermanac’h, N., Cohen-Solal, M. E., Bessis, N., de Vernejoul, M. C., & Boissier, M. (2004) · Revue du Rhumatisme · doi:10.1016/s1169-8330(03)00331-4 · Cited by 2
Influence of osteoprotegerin (OPG) on experimentally induced ectopic bone
Włodarski, K. H., Kochanowska, I. E., Pieńkowski, M., & Ostrowski, K. (2004) · Folia Biologica · doi:10.3409/1734916044527520 · Cited by 2
The development of supportive-care agents for patients with cancer
Neumann, T., & Foote, M. (2003) · Biotechnology annual review · doi:10.1016/s1387-2656(03)09011-2 · Cited by 2
Osteoclastogénesis y enfermedades óseas
Mikán, V. J. F., & Oliveros, A. W. D. (2007) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 2
Song, C., Zhou, Y., Luo, Y., Wang, L., Liu, T., Zhou, D., Liu, F., Chen, J., Fu, Z., Chen, F., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103326 · Cited by 1
Mundy, G. R., Oyajobi, B. O., Gutierrez, G., Sterling, J. A. R., Padalecki, S. S., Elefteriou, F., & Zhao, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375098-3.50019-6 · Cited by 1
The differential effects of two critical osteoclastogenesis stimulating factors on bone biomechanics
Yuan, Y. (2007) · TigerPrints (Clemson University) · Cited by 1
OPG, RANK and RANKL in Bone Metastasis and Cancer-Associated Osteolysis
Kostenuik, P. J. (2004) · Cancer metastasis · doi:10.1007/978-1-4020-2036-0_11 · Cited by 1
Stern, P. H. (2005) · Elsevier eBooks · doi:10.1016/b978-012252687-9/50035-8 · Cited by 1
Morton, A. R., & Lipton, A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50052-x · Cited by 1
Bolon, B. N., Shalhoub, V., Kostenuik, P. J., Zack, D. J., & Feige, U. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7883-8_10
Bedeutung von RANK-Ligand und Osteoprotegerin für den Knochenstoffwechsel
Hofbauer, L. C., & Schoppet, M. (2006) · Springer eBooks · doi:10.1007/3-540-28782-5_21
Kong, Y., & Penninger, J. M. (2003) · doi:10.1007/978-1-59259-405-4_23
Bone metabolism and inflammatory bowel disease
Abreu, M. T. (2007) · Springer eBooks · doi:10.1007/0-387-25808-6_49
Kendler, D. L. (2010) · Orthopedic Research and Reviews · doi:10.2147/orr.s6124
Croucher, P. I. (2004) · PubMed
Dietary Calcium and Osteoprotegerin
Sun, D., Yu, J., Gao, Y., & Li, Y. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622130-00547
Physiologic Actions of PTH and PTHrP
WLER, G. J. S. (2001) · Elsevier eBooks · doi:10.1016/b978-012098651-4/50015-8
Parathyroid Hormone and Calcium Homeostasis
Strewler, G. J. (2003) · Elsevier eBooks · doi:10.1016/b978-012286551-0/50007-5
New Approaches to Osteoporosis Therapeutics
Stoch, S. A., Chorev, M., & Rosenblatt, M. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50080-5
Novel cytokines in growth control and bone disease of multiple myeloma
Hjorth‐Hansen, H. (2001) · BIBSYS Brage (BIBSYS (Norway))
Bone metabolism and inflammatory bowel disease
Abreu, M. T. (2003) · Springer eBooks · doi:10.1007/978-1-4020-3477-0_49
Morton, A. R., & Lipton, A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00037-0
Translational Pharmacology in The Development of RANKL Inhibitors
Boyce, B. F., & Yao, Z. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.62262-6
Guidon, C. (2005) · EMC - Anestesia-Reanimación · doi:10.1016/s1280-4703(05)44227-9
Guidon, C. (2005) · EMC-Anesthésie réanimation/Encyclopédie médico-chirurgicale. Anesthésie, réanimation · doi:10.1016/s0246-0289(05)30097-1
Melemedjian, O. K. (2007) · UA Campus Repository (The University of Arizona)
Metadata
- Authors
- Morony, S., Capparelli, C., Lee, R., Shimamoto, G., Boone, T., Lacey, D. L., & Dunstan, C. R.
- Affiliations
- Amgen (United States) (US)
- Corresponding author
- Dunstan, Colin R.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-09-01
- Volume
- 14
- Issue
- 9
- Pages
- 1478-1485
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2050716165
- Cited by
- 187
- References
- 43
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2022: 2 · 2020: 3 · 2019: 4 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 3 · 2013: 2 · 2012: 7
- FWCI
- 6.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amgen
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- osteoprotegerin, hypercalcemia, bone resorption, osteoclasts, IL-1β, TNF-α, parathyroid hormone, parathyroid hormone-related protein, 1,25-dihydroxyvitamin D3, hyperparathyroidism, humoral hypercalcemia of malignancy, osteoporosis, inflammatory bone disease, bone metabolism
- MeSH terms
- Animals, Bone and Bones, Bone Resorption, Calcitriol, Calcium, Cell Count, Glycoproteins, Humans, Hypercalcemia, Interleukin-1, Isomerism, Male, Osteoclasts, Parathyroid Hormone, Proteins, Radiography, Tumor Necrosis Factor-alpha, Weight Loss, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Parathyroid Hormone-Related Protein, Mice, Osteoprotegerin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
